{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/05/3287664/0/en/Oragenics-Activates-Second-Site-in-Phase-IIa-Clinical-Trial-of-ONP-002-for-Concussion-and-Mild-Traumatic-Brain-Injury.html", "message": "News view counter 703119 successfully enlarged"}